Kalos Management’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,228
| Closed | -$58K | – | 285 |
|
|
2021
Q3 | $58K | Sell |
2,228
-93
| -4% | -$2.42K | 0.02% | 288 |
|
|
2021
Q2 | $74K | Sell |
2,321
-54
| -2% | -$1.72K | 0.03% | 259 |
|
|
2021
Q1 | $83K | Hold |
2,375
| – | – | 0.03% | 286 |
|
|
2020
Q4 | $112K | Hold |
2,375
| – | – | 0.05% | 237 |
|
|
2020
Q3 | $79K | Sell |
2,375
-66
| -3% | -$2.2K | 0.04% | 223 |
|
|
2020
Q2 | $107K | Sell |
2,441
-134
| -5% | -$5.87K | 0.05% | 204 |
|
|
2020
Q1 | $86K | Buy |
2,575
+134
| +5% | +$4.48K | 0.04% | 191 |
|
|
2019
Q4 | $121K | Hold |
2,441
| – | – | 0.04% | 188 |
|
|
2019
Q3 | $90K | Buy |
2,441
+133
| +6% | +$4.9K | 0.04% | 186 |
|
|
2019
Q2 | $127K | Buy |
2,308
+157
| +7% | +$8.64K | 0.06% | 180 |
|
|
2019
Q1 | $130K | Sell |
2,151
-290
| -12% | -$17.5K | 0.08% | 146 |
|
|
2018
Q4 | $147K | Buy |
2,441
+133
| +6% | +$8.01K | 0.07% | 173 |
|
|
2018
Q3 | $180K | Buy |
2,308
+1,175
| +104% | +$91.6K | 0.1% | 143 |
|
|
2018
Q2 | $244K | Buy |
+1,133
| New | +$244K | 0.11% | 167 |
|
|
2018
Q1 | – | Sell |
-1,613
| Closed | -$222K | – | 159 |
|
|
2017
Q4 | $222K | Buy |
+1,613
| New | +$222K | 0.1% | 187 |
|